BEAM-301 — Initial data
2026
Beam expects to report initial clinical data in 2026.Source filing
BEAM biotech catalysts & pipeline
BEAM THERAPEUTICS INC · Data as of 2026-09-08
Upcoming catalysts
ristoglogene autogetemcel (risto-cel) — Topline data
Late 2026
Beam expects to report updated data for the BEACON trial by year-end 2026 and submit a biologics license application (BLA) for risto-cel as early as year-end 2026.Source filing
BEAM-302 — Conference presentation
Sep 5–Sep 9
Detailed and updated clinical data for BEAM-302 were selected for a late-breaking oral presentation at the European Respiratory Society (ERS) Congress, taking place September 5-9, 2026, in Barcelona, Spain.Source filing